GBV-C virus and fulminant hepatic failure

Reviewing hepatitis B virus (HBV)-related mortality in Birmingham (2018-2023): The impact of late diagnosis.

Public health·2026

Outcomes of normothermic machine perfusion of liver grafts in repeat liver transplantation (NAPLES initiative).

The British journal of surgery·2022

Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.

Transplantation proceedings·2017

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England.

Journal of viral hepatitis·2016

Outcome of liver transplantation in patients with hereditary bleeding disorders: a single centre UK experience.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II).

Alimentary pharmacology & therapeutics·2015

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Effects of pharmacological blood pressure lowering in heart failure with mildly reduced or preserved ejection fraction: a meta-analysis.

Heart (British Cardiac Society)·2026

A cross-sectional online survey evaluating how anaesthesiologists view cardiovascular magnetic resonance imaging reports as a tool for perioperative risk evaluation.

BJA open·2026

Exercise-based rehabilitation with or without blood flow restriction in individuals with heart failure: Protocol for the rehab-washout HF trial.

JSAMS plus·2026

When SVT is Not Benign: Troponin Elevation Revealing Coronary Vasospasm, A Case Report.

Clinical medicine insights. Case reports·2026

Determinants of hospitalization among Indonesian Hajj pilgrims in Saudi Arabia: a nationwide retrospective cohort study.

Annals of Saudi medicine·2026

Primary graft dysfunction after heart transplantation: Impaired metabolic recovery as an emerging mechanism.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Related Experiment Videos

GBV-C virus and fulminant hepatic failure

Related Concept Videos

Reviewing hepatitis B virus (HBV)-related mortality in Birmingham (2018-2023): The impact of late diagnosis.

Outcomes of normothermic machine perfusion of liver grafts in repeat liver transplantation (NAPLES initiative).

Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England.

Outcome of liver transplantation in patients with hereditary bleeding disorders: a single centre UK experience.

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II).

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Effects of pharmacological blood pressure lowering in heart failure with mildly reduced or preserved ejection fraction: a meta-analysis.

A cross-sectional online survey evaluating how anaesthesiologists view cardiovascular magnetic resonance imaging reports as a tool for perioperative risk evaluation.

Exercise-based rehabilitation with or without blood flow restriction in individuals with heart failure: Protocol for the rehab-washout HF trial.

When SVT is Not Benign: Troponin Elevation Revealing Coronary Vasospasm, A Case Report.

Determinants of hospitalization among Indonesian Hajj pilgrims in Saudi Arabia: a nationwide retrospective cohort study.

Primary graft dysfunction after heart transplantation: Impaired metabolic recovery as an emerging mechanism.

Related Experiment Videos

GBV-C virus and fulminant hepatic failure

Related Concept Videos

Related Articles